Shigeru Kotake

Dr. Shigeru Kotake

Tokyo Women's Medical University, Institute of Rheumatology, Tokyo, Japan

Research Focus & Metrics

Academic Career Length

11Years (2016-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
Verified
Journal Article
Open access
PDF file
SKShigeru Kotake
Shigeru Kotake
TYToru Yago
Toru Yago
TKTsuyoshi Kobashigawa
Tsuyoshi Kobashigawa
YNYuki Nanke
Yuki Nanke
Helper T (Th) cells play an important role in the pathogenesis of autoimmune diseases, including rheumatoid arthritis (RA). It has been revealed that Th17 cells can shift to Th1 cells (i.e., “nonclassic Th1 cells”), which are reported to be more pathogenic than Th17 cells per se. Thus, the association of Th cells in the pathogenesis of autoimmune disease has become more complicated. We recently reported using peripheral blood from untreated and early-onset RA patients that the ratio of CD161+Th1 cells (i.e., Th17-derived Th1 cells to CD161+Th17 cells) is elevated and that levels of interferon-γ (IFNγ)+Th17 cells are inversely correlated with levels of anti-CCP antibodies. Here, we review the plasticity of Th17 cells in the pathogenesis of RA, suggesting possible implications for novel therapies.

29 August 2017 in Journal of Clinical Medicine
Verified
Journal Article
Open access
PDF file
TYToru Yago
Toru Yago
YNYuki Nanke
Yuki Nanke
MKManabu Kawamoto
Manabu Kawamoto
TKTsuyoshi Kobashigawa
Tsuyoshi Kobashigawa
HYHisashi Yamanaka
Hisashi Yamanaka
SKShigeru Kotake
Shigeru Kotake
IL-23, which is composed of p19 and p40 subunits, is a proinflammatory cytokine that contributes to the formation and maintenance of Th17 cells in inflammatory autoimmune diseases. IL-23 is a human osteoclastogenic cytokine and anti-IL-23 antibody attenuates paw volume and joint destruction in CIA rats. IL-23 levels in serum and synovial fluid are high in rheumatoid arthritis (RA) patients, and IL-23 may be a useful biomarker for the diagnosis of RA. In addition, IL-23 affects the pathogenesis of inflammation and bone destruction through interaction with other cytokines such as IL-17 and TNF-α. Furthermore, polymorphisms of IL23R are a risk factor for ankylosing spondylitis (AS) and psoriatic arthritis (PsA), which indicates that IL-23 is also involved in the pathogenesis of spondyloarthritis (SpA). Finally, IL-17 and IL-23 inhibitors reduce the clinical manifestations of SpA. Thus, the IL-23/Th17 pathway is a therapeutic target for the treatment of inflammatory arthritis.

Verified
Journal Article
Open access
PDF file
YNYuki Nanke
Yuki Nanke
TYToru Yago
Toru Yago
SKShigeru Kotake
Shigeru Kotake
Behcet’s disease (BD) is a polysymptomatic and recurrent systemic vasculitis with a chronic course and unknown cause. The pathogenesis of BD has not been fully elucidated; however, BD has been considered to be a typical Th1-mediated inflammatory disease, characterized by elevated levels of Th1 cytokines such as IFN-γ, IL-2, and TNF-α. Recently, some studies reported that Th17-associated cytokines were increased in BD; thus, Th17 cells and the IL17/IL23 pathway may play important roles in the pathogenesis of BD. In this chapter, we focus on the pathogenic role of Th17 cells in BD.

1 May 2016 in The American Journal of Pathology
Verified
Journal Article
Closed access
SKShigeru Kotake
Shigeru Kotake
YNYuki Nanke
Yuki Nanke